Risk of Myocarditis and Pericarditis Following COVID-19 mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada
JAMA Netw Open 2022 Jun 01;5(6)e2218505, SA Buchan, CY Seo, C Johnson, S Alley, JC Kwong, S Nasreen, A Calzavara, D Lu, TM Harris, K Yu, SE WilsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.